遗传性伪胆酶缺乏症和顺胆:历史视角,治疗影响和未来考虑
Jenny Q Nguyen1, Courtney Paetznick2, Roseann S Donnelly3
1Personalized Care Program, Children's Hospital Los Angeles, California, Los Angeles, USA.
针对伪胆酶缺乏症 (BCHE) 的遗传检测可以预防因顺胆而导致的长期. 早期识别BCHE变异可确保患者的安全,避免严重的并发症.
科学领域:
- 药物基因组学 药物基因组学
- 临床化学 临床化学
- 麻醉学 麻醉学
背景情况:
- 苏奇尼尔胆是一种广泛使用的神经肌肉阻断剂,由伪胆化酶 (丁胆化酶) 水解.
- 在BCHE基因中的遗传变异可以导致酶活性降低,增加长期神经肌肉阻塞的风险.
- 尽管BCHE测试是早期的药物基因组学发现,但它并未经常使用.
研究的目的:
- 审查伪胆酶缺乏症的病史和治疗影响.
- 探索BCHE基因测试在预防因顺胆引起的长期方面的作用.
- 批判性地检查BCHE遗传测试和 succinylcholine反应的现有文献.
主要方法:
- 文献综述和发表研究的批判性检查.
- 分析与BCHE基因变异和顺胆代谢相关的药物基因组数据.
- 探索历史背景和临床实施挑战.
主要成果:
- 由BCHE基因变异引起的伪胆酶缺乏症是长期基尼胆阻塞的已知危险因素.
- 预防性BCHE基因测试可以识别有风险的个体.
- 目前BCHE测试的临床实施有限,但建议用于预防不良事件.
结论:
- 预防性BCHE基因测试对于识别容易患上长期的个人至关重要.
- 实施BCHE测试可以减轻严重的身体 (如呼吸暂停) 和心理 (如PTSD) 后果.
- 进一步将BCHE遗传检测纳入临床实践是有必要的,以提高麻醉患者的安全性.
更多相关视频
10:16In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
07:09Subcutaneous Administration of Muscarinic Antagonists and Triple-Immunostaining of the Levator Auris Longus Muscle in Mice
Published on: September 8, 2011
相关概念视频
Depolarizing Blockers: Pharmocokinetics
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
